EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA

Detalles Bibliográficos
Autores principales: ROY, ARCHANA, NAGA YARRARAPU, SIVA, NAZARENO, MARK, SANGHAVI, DEVANG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:
Critical Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503101/
http://dx.doi.org/10.1016/j.chest.2021.07.1013
_version_ 1784581038392999936
author ROY, ARCHANA
NAGA YARRARAPU, SIVA
NAZARENO, MARK
SANGHAVI, DEVANG
author_facet ROY, ARCHANA
NAGA YARRARAPU, SIVA
NAZARENO, MARK
SANGHAVI, DEVANG
author_sort ROY, ARCHANA
collection PubMed
description
format Online
Article
Text
id pubmed-8503101
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85031012021-10-12 EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA ROY, ARCHANA NAGA YARRARAPU, SIVA NAZARENO, MARK SANGHAVI, DEVANG Chest Critical Care American College of Chest Physicians. Published by Elsevier Inc. 2021-10 2021-10-11 /pmc/articles/PMC8503101/ http://dx.doi.org/10.1016/j.chest.2021.07.1013 Text en Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Critical Care
ROY, ARCHANA
NAGA YARRARAPU, SIVA
NAZARENO, MARK
SANGHAVI, DEVANG
EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
title EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
title_full EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
title_fullStr EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
title_full_unstemmed EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
title_short EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
title_sort early discontinuation of antibiotics based on procalcitonin level in covid-19 pneumonia
topic Critical Care
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503101/
http://dx.doi.org/10.1016/j.chest.2021.07.1013
work_keys_str_mv AT royarchana earlydiscontinuationofantibioticsbasedonprocalcitoninlevelincovid19pneumonia
AT nagayarrarapusiva earlydiscontinuationofantibioticsbasedonprocalcitoninlevelincovid19pneumonia
AT nazarenomark earlydiscontinuationofantibioticsbasedonprocalcitoninlevelincovid19pneumonia
AT sanghavidevang earlydiscontinuationofantibioticsbasedonprocalcitoninlevelincovid19pneumonia

Ejemplares similares